Wiley Bros. Aintree Capital, LLC United Therapeutics Corp Transaction History
Wiley Bros. Aintree Capital, LLC
- $9.13 Billion
- Q1 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 1,775 shares of UTHR stock, worth $515,442. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,775
Previous 1,266
40.21%
Holding current value
$515,442
Previous $446,000
22.65%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding UTHR
# of Institutions
733Shares Held
43.6MCall Options Held
124KPut Options Held
122K-
Black Rock Inc. New York, NY5.47MShares$1.59 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.29 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$777 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$648 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$612 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...